연구성과로 돌아가기

2021 연구자 정보 (860 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Gholaminezhad, Iman
(Gholaminezhad, I) ⓘ 		Univ Guilan, Fac Mech Engn, Rasht, Iran ⓘ
ⓘ
ⓘ 		[JCR상위 44.5] Robust controller design for systems with probabilistic uncertain parameters using multi-objective genetic programming ⓘ SCIE ⓘ 44.5 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS ⓘ mallipeddi.ram@gmail.com;ali.jamali@guilan.ac.ir; ⓘ
Jamali, Ali
(Jamali, A) ⓘ 		Univ Guilan, Fac Mech Engn, Rasht, Iran
Univ Guilan, Dept Mech Engn, Univ Campus 2, Rasht, Iran ⓘ 		AAX-5841-2020
Jamali, Ali ⓘ 		0000-0003-2592-6187
Jamali, Ali ⓘ 		[JCR상위 44.5] Robust controller design for systems with probabilistic uncertain parameters using multi-objective genetic programming ⓘ SCIE ⓘ 44.5 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS ⓘ mallipeddi.ram@gmail.com;ali.jamali@guilan.ac.ir; ⓘ
Saeedi, Mohammad S.
(Saeedi, MS) ⓘ 		Univ Guilan, Fac Mech Engn, Rasht, Iran
Univ Guilan, Dept Mech Engn, Univ Campus 2, Rasht, Iran ⓘ 		AFQ-1644-2022
Saeedi, Mohammad ⓘ
ⓘ 		[JCR상위 44.5] Robust controller design for systems with probabilistic uncertain parameters using multi-objective genetic programming ⓘ SCIE ⓘ 44.5 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS ⓘ mallipeddi.ram@gmail.com;ali.jamali@guilan.ac.ir; ⓘ
Abdel-Razeq, Hikmat
(Abdel-Razeq, H) ⓘ 		King Hussein Canc Ctr, Amman, Jordan ⓘ
ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
Adhav, Aditya
(Adhav, A) ⓘ 		HCG Manavata Canc Ctr, Dept Surg Oncol, Nasik, India ⓘ
ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
Aksoy, Sercan
(Aksoy, S) ⓘ 		Hacettepe Univ, Med Fac, Ankara, Turkey ⓘ S-2480-2019
Aksoy, Sercan ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
Bowles, James
(Bowles, J) ⓘ 		Novartis Pharma AG, Basel, Switzerland ⓘ
ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
Chae, Yeesoo
(Chae, Y) ⓘ 		Kyungpook Natl Univ Hosp, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
Chang, Yuan-Ching
(Chang, YC) ⓘ 		Mackay Mem Hosp, Taipei, Taiwan ⓘ
ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
Cinkir, Havva Yesil
(Cinkir, HY) ⓘ 		Gaziantep Univ, Dept Med Oncol, Med Fac, Gaziantep, Turkey ⓘ
ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
Im, Seock-Ah
(Im, SA) ⓘ 		Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp, Seoul, South Korea ⓘ J-5620-2012
Im, Seock-Ah ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
Im, Young-Hyuck
(Im, YH) ⓘ 		제1저자 교신저자 Sungkyunkwan Univ, Div Hematol Oncol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
Jeong, Joon
(Jeong, J) ⓘ 		Yonsei Univ Hlth Syst, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea
Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea ⓘ
ⓘ 		0000-0003-0397-0005
Jeong, Joon ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES
[JCR상위 74.9] A Randomized Controlled Trial for Doing vs. Omitting Intraoperative Frozen Section Biopsy for Resection Margin Status in Selected Patients Undergoing Breast-Conserving Surgery (OFF-MAP Trial) ⓘ 		SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu;
bjchae@gmail.com; ⓘ
Karabulut, Bulent
(Karabulut, B) ⓘ 		Ege Univ, Dept Med Oncol, Fac Med, Izmir, Turkey ⓘ
ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
Kim, Sung-Bae
(Kim, SB) ⓘ 		Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea ⓘ JXL-8219-2024
Kim, Sung-Bae ⓘ
ⓘ 		[JCR상위 44.7] Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES ⓘ SCIE ⓘ 44.7 ONCOLOGY ⓘ imyh00@skku.edu; ⓘ
페이지 이동: